H.R. 1526 · 118th Congress
Reducing Hereditary Cancer Act
- Stage
- In committee
- Sponsor
- Debbie Wasserman Schultz
- Introduced
- 2023-03-09
- Latest action
- 2024-12-17 · Referred to the Subcommittee on Health.
Summary
Reducing Hereditary Cancer Act
This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.